Bioject Medical Technologies Inc. (OTC:BJCT) Signs An Investment Agreement
Posted on | August 31, 2011 | No Comments
On Monday, Bioject Medical Technologies Inc. (OTC:BJCT) signed an investment agreement with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership (Dutchess).
According the contract, Dutchess may sale of up to $5.0 million shares of Bioject’s common stock over a three year period.
Thanks to the agreement, BJCT may not only improve the low volatility of its stock. The company as well preconditions its fluent operations through ensuring regular cash flows.
The companies agreed, that Bioject Medical Technologies Inc. may in its discretion, sell newly-issued shares to Dutchess. BJCT has the right to receive advances, generally limited to $100 thousand.
Bioject Medical Technologies Inc. offers a portfolio of needle-free injection products to meet the varied needs of today’s healthcare environment. The company has been incorporated in 1985 with a main focus on developing needle-free injection technology.
Comments
Leave a Reply